Invesco’s ADMA Biologics ADMA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$37.1M Sell
4,119,577
-7,665,625
-65% -$121M 0.01% 1189
2025
Q4
$215M Sell
11,785,202
-720,276
-6% -$12.1M 0.03% 651
2025
Q3
$183M Sell
12,505,478
-312,663
-2% -$5.36M 0.03% 696
2025
Q2
$233M Sell
12,818,141
-48,763
-0.4% -$994K 0.04% 570
2025
Q1
$255M Buy
12,866,904
+1,570,649
+14% +$27.2M 0.05% 505
2024
Q4
$194M Sell
11,296,255
-1,323,514
-10% -$24.9M 0.04% 638
2024
Q3
$252M Sell
12,619,769
-550,967
-4% -$8.57M 0.05% 511
2024
Q2
$147M Buy
13,170,736
+5,366,509
+69% +$45M 0.03% 672
2024
Q1
$51.5M Buy
7,804,227
+1,692,454
+28% +$9.25M 0.01% 1014
2023
Q4
$27.6M Buy
6,111,773
+694,607
+13% +$2.57M 0.01% 1255
2023
Q3
$19.4M Buy
5,417,166
+426,446
+9% +$1.64M 0.01% 1356
2023
Q2
$18.4M Buy
4,990,720
+164,104
+3% +$608K ﹤0.01% 1412
2023
Q1
$16M Buy
4,826,616
+615,141
+15% +$2.13M ﹤0.01% 1469
2022
Q4
$16.3M Buy
4,211,475
+785,726
+23% +$2.42M ﹤0.01% 1491
2022
Q3
$8.32M Buy
3,425,749
+3,109,896
+985% +$7.46M ﹤0.01% 1918
2022
Q2
$625K Sell
315,853
-113,610
-26% -$224K ﹤0.01% 3225
2022
Q1
$786K Sell
429,463
-130,463
-23% -$204K ﹤0.01% 3187
2021
Q4
$789K Buy
+559,926
New +$736K ﹤0.01% 3189
2021
Q2
Sell
-17,896
Closed -$31K 3958
2021
Q1
$31K Buy
17,896
+3,602
+25% +$8.24K ﹤0.01% 3845
2020
Q4
$28K Buy
+14,294
New +$30K ﹤0.01% 3756
2019
Q4
Sell
-162,632
Closed -$724K 3648
2019
Q3
$724K Buy
+162,632
New +$680K ﹤0.01% 3132
2019
Q2
Sell
-54,729
Closed -$207K 3712
2019
Q1
$207K Buy
54,729
+4,422
+9% +$15.6K ﹤0.01% 3615
2018
Q4
$120K Sell
50,307
-11,099
-18% -$55K ﹤0.01% 3624
2018
Q3
$381K Buy
61,406
+15,133
+33% +$87.1K ﹤0.01% 3537
2018
Q2
$209K Buy
+46,273
New +$231K ﹤0.01% 3693

Other funds holding ADMA